We are live on ! Find out more
AGN

Allergan plc
AGN

Delisted

AGN was delisted on the 8th of May, 2020.

479 hedge funds and large institutions have $16.1B invested in Allergan plc in 2013 Q3 according to their latest regulatory filings, with 65 funds opening new positions, 166 increasing their positions, 194 reducing their positions, and 94 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% more call options, than puts

Call options by funds: $342M | Put options by funds: $171M

9% more capital invested

Capital invested by funds: $14.7B → $16.1B (+$1.39B)

6% less funds holding in top 10

Funds holding in top 10: 3230 (-2)

6% less funds holding

Funds holding: 512479 (-33)

14% less repeat investments, than reductions

Existing positions increased: 166 | Existing positions reduced: 194

31% less first-time investments, than exits

New positions opened: 65 | Existing positions closed: 94

Holders
479
Holders Change
-33
Holders Change %
-6.45%
% of All Funds
15.53%
Holding in Top 10
30
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-6.25%
% of All Funds
0.97%
New
65
Increased
166
Reduced
194
Closed
94
Calls
$342M
Puts
$171M
Net Calls
+$170M
Net Calls Change
+$45M
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$1.63B +$210M +1,575,701 +16%
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.16B -$57.8M -433,670 -5%
State Street
3
State Street
Massachusetts
$885M +$126M +943,258 +18%
Wellington Management Group
4
Wellington Management Group
Massachusetts
$668M +$25.1M +188,562 +4%
BIT
5
BlackRock Institutional Trust
California
$586M +$92.1M +691,120 +20%
Viking Global Investors
6
Viking Global Investors
Connecticut
$468M +$244M +1,829,186 +129%
Franklin Resources
7
Franklin Resources
California
$449M -$50.1M -375,734 -11%
Lord, Abbett & Co
8
Lord, Abbett & Co
New Jersey
$439M -$72.1M -541,348 -15%
Bank of New York Mellon
9
Bank of New York Mellon
New York
$346M +$36.9M +277,204 +13%
JHIU
10
Janus Henderson Investors US
Colorado
$326M -$35.2M -264,533 -10%
BFA
11
BlackRock Fund Advisors
California
$290M +$35.7M +267,705 +15%
PI
12
Putnam Investments
Massachusetts
$248M +$48.4M +363,554 +27%
FAM
13
Fred Alger Management
New York
$242M +$51.6M +387,568 +30%
JP Morgan Chase
14
JP Morgan Chase
New York
$241M +$29.6M +221,974 +15%
Wells Fargo
15
Wells Fargo
California
$221M +$157M +1,181,204 +333%
VOYA Investment Management
16
VOYA Investment Management
Georgia
$214M +$4.35M +32,675 +2%
TCIM
17
TIAA CREF Investment Management
New York
$213M -$21.6M -161,813 -10%
T. Rowe Price Associates
18
T. Rowe Price Associates
Maryland
$208M +$104M +783,578 +119%
SIG
19
Senator Investment Group
New York
$205M -$32.2M -241,885 -15%
Westfield Capital Management
20
Westfield Capital Management
Massachusetts
$199M -$3.41M -25,608 -2%
Goldman Sachs
21
Goldman Sachs
New York
$195M -$21.8M -163,344 -11%
CCI
22
Columbus Circle Investors
$186M +$34.8M +261,500 +25%
Northern Trust
23
Northern Trust
Illinois
$181M -$66.4M -498,466 -28%
Ameriprise
24
Ameriprise
Minnesota
$177M -$34.7M -260,246 -17%
Geode Capital Management
25
Geode Capital Management
Massachusetts
$173M +$44.7M +335,629 +39%

AGN Hedge Fund Activity: Q3 2013 in Review

479 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q3 2013, worth a combined $16.1B — up 9.4% from $14.7B a quarter earlier.

Sellers outnumbered buyers: 94 funds closed out of AGN and 65 opened new positions — a net loss of 29 holders — while 194 trimmed existing stakes and 166 added.

The largest buyer was Viking Global Investors, adding an estimated $244M. The largest seller was OppenheimerFunds, cutting an estimated $440M.

  • 479 institutional investors held Allergan plc (AGN) as of Q3 2013, down from 512 in Q2 2013.
  • Funds reported $16.1B of Allergan plc stock for Q3 2013, up 9.4% quarter-over-quarter.
  • 65 funds opened new Allergan plc positions in Q3 2013 and 94 closed out, a net change of -29 holders.
  • The largest Allergan plc buyer in Q3 2013 was Viking Global Investors, an estimated $244M added.
  • The largest Allergan plc seller in Q3 2013 was OppenheimerFunds, an estimated $440M sold.

Based on aggregated 13F filings for Q3 2013.